-
November 3, 2023 FOQUEST now on the Alberta Drug Benefit ListEffective November 1, 2023, FOQUEST is now listed on the Alberta Drug Benefit List for the treatment...
-
November 1, 2023 Vyvanse added to innoviCares programVyvanse has been added to the innoviCares program. As part of the program,patients automatically get 5% off...
-
June 27, 2023 Advocacy Update – June 2023 – Meetings with Provincial MinistersAdvocacy Update – Meetings with Provincial Ministers – June 2023 CADDRA and CADDAC had two...
-
January 12, 2022 A program to improve the assessment of a child for attention deficit hyperactivity disorderA program to improve the assessment of a child for attention deficit hyperactivity disorder Lukomski...
-
January 11, 2022 CONCERTA has now been updated to full benefit status in Nova Scotia, New Brunswick and Newfoundland & LabradorCONCERTA® has now been updated to full benefit status in Nova Scotia, New Brunswick and Newfoundland...
-
January 11, 2022 FOQUEST has now been included on the Manitoba formulary as of November 2021FOQUEST™ has now been included on the Manitoba formulary for public reimbursement for ADHD...
-
December 1, 2021 Childhood ADHD Symptoms, Parent Emotion Socialization, and Adolescent Peer Problems: Indirect Effects Through Emotion DysregulationChildhood ADHD Symptoms, Parent Emotion Socialization, and Adolescent Peer Problems: Indirect Effects Through Emotion Dysregulation...
-
November 17, 2021 Variable Patterns of Remission from ADHD in the Multimodal Treatment Study of ADHDVariable Patterns of Remission from ADHD in the Multimodal Treatment Study of ADHD Sibley MH,...
-
November 3, 2021 Annual Research Review: Attention-deficit/hyperactivity disorder in girls and women: underrepresentation, longitudinal processes, and key directionsAnnual Research Review: Attention-deficit/hyperactivity disorder in girls and women: underrepresentation, longitudinal processes, and key directions...
-
October 27, 2021 alpha2-Adrenergic Agonists or Stimulants for Preschool-Age Children with Attention-Deficit/Hyperactivity Disorderalpha2-Adrenergic Agonists or Stimulants for Preschool-Age Children with Attention-Deficit/Hyperactivity Disorder Harstad E, Shults J, Barbaresi...
